Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 14/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.55 |
| ▸ | JAK3 | P52333 | 2/20 | 0.45 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3678265 | 0.87 | JAK2 (0.55) | JAK2KCNH2JAK3TNIKCHEK1 | |
| SCHEMBL3510295 | 0.86 | JAK2 (0.58) | JAK2KCNH2JAK3TNIKGRM2 | |
| SCHEMBL3674712 | 0.86 | JAK2 (0.62) | JAK2KCNH2JAK3TNIKCHEK1 | |
| SCHEMBL3670415 | 0.86 | JAK2 (0.58) | JAK2KCNH2JAK3GRM2 | |
| SCHEMBL3677021 | 0.85 | JAK2 (0.75) | JAK2KCNH2JAK3TNIKCHEK1 | |
| SCHEMBL3674452 | 0.85 | JAK2 (0.59) | JAK2KCNH2JAK3GRM2 | |
| SCHEMBL3679261 | 0.84 | JAK2 (0.58) | JAK2KCNH2JAK3GRM2 | |
| SCHEMBL3671863 | 0.83 | JAK2 (0.54) | JAK2KCNH2JAK3 | |
| SCHEMBL3674552 | 0.83 | JAK2 (0.54) | JAK2KCNH2JAK3GRM2CHEK1 | |
| SCHEMBL3675459 | 0.83 | JAK2 (0.57) | JAK2KCNH2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2166846-A1 | INHIBITORS OF JANUS KINASES | Merck Sharp & Dohme Corp. (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008156726-A1 | INHIBITORS OF JANUS KINASES | MERCK & CO., INC. (US) | 2008-12-24 | — | — | WO | disclosed |